维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

8篇 您的检索式：作者名="Guijo"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis:Does it really save lives?显示文摘The treatment of peritoneal carcinomatosis (PC) of colorectal origin with cytoreductive surgery(CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has a 5-year recurrence-free or cure rate of at least 16%, so it is no longer labeled as a fatal disease, and offers prolonged survival for patients with a low peritoneal carcinomatosis index. Metachronous PC of colorectal origin is so predictable that there is a model which has been used to successfully determine the individual risk of each patient. Patients at risk are clearly identified; those with the highest risk have small peritoneal nodules present in the first surgery (70% probability of developing PC), ovarian metastases(60%), perforated tumor onset or intraoperative tumor rupture(50%). Current clinical, biological and imaging techniques still lack sufficient sensitivity to diagnose PC in its initial stages, when CRS plus HIPEC has a greater impact and a higher cure rate. Second-look surgery with HIPEC or prophylactic HIPEC at the time of the first intervention have been proposed as means of preventing and/or anticipating clinical or radiological relapse in at-risk patients. Both techniques have shown a significant decrease in peritoneal relapses and should be considered essential weapons in the management of colorectal cancer.	Delia Cortes-Guiral Dominique Elias Pedro Antonio Cascales-Campos Alfredo Badía Yébenes Ismael Guijo Castellano Ana Isabel León Carbonero JoséIgnacio Martín Valadés Jesus Garcia-Foncillas Damian Garcia-Olmo	2017	World Journal of Gastroenterology2017，23，3：	3
	2	Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena 显示文摘	Ocio EM Sanchez - Guijo FM Diez - Campelo M	2005	Am J Hematol2005，78，：	1
	3	Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena 显示文摘	Ocio EM Sanchez - Guijo FM Diez - Campelo M	2005	AmJ Hematol2005，78，4：	1
	4	Multiparametric compari-son of mesenchymal stromal cells obtained from trabecular bone by usinga novel isolation method with those obtained by iliac crest aspirationfrom the same subjects显示文摘	Sanchez -Guijo FM Blanco JF Cruz G	2009	Cell Tissue Res2009，336，3：	1
	5	Mielitis transversa en síndrome de Sj?gren y lupus eritematoso sistémico: presentación de 3 casos显示文摘	Raúl Menor Almagro María del Mar Ruiz Tudela Juan Girón úbeda Mario H. Cardiel Rios José Javier Pérez Venegas Carmen García Guijo	2014	Reumatologia Clinica2014，，：	1
	6	Isolation and characterization of mesenchymal stromal cells from human degen-erated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects显示文摘	BlancoJF Graciani IF Sanchez - Guijo FM	2010	Spine (Phila Pa 1976)2010，35，26：	1
	7	Tumor necrosis factor - alpha levels in aqueous hu- mor and serum from patients with uveitis : the involvement of HLA - B271 显示文摘	PEREZ GUIJO V SANTOS LACOMBA M SANCHEZ HERNAN- DEZ M	2004	Curr Med Res Opin2004，20，：	1
	8	Wenzhou Moves on witha More Diversified Banking Sector显示文摘ZHEJIANG is one of the richest and most developed provinceson China’s mainland. It has been leading economic growth since	DARIO GUIJO	2012	China Today2012，61，11：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费